EBERINI, IVANO
EBERINI, IVANO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Modulating mAbs Function through Glycosylation and Isotype: A Molecular Dynamics Perspective
2026 D. Bianchi, S. Saporiti, O. Ben Mariem, F. Centola, I. Eberini
Tavola rotonda. Il confronto tra gli stakeholder
2026 P. Blasi, I. Eberini, F. Russo, S. Mallamaci, A. Mandelli, M. Pellegrini Calace, G. Vistoli
Mechanistic Insights into Lysine Cyclodeaminase Catalysis
2026 Y. Wei, U. Guerrini, I. Eberini
Approccio in silico per la valutazione dei singoli composti
2026 L. Palazzolo, O. Ben Mariem, I. Eberini
Structure-Guided Prioritization and Synthesis of New Ligands for GPR17 Receptor
2026 M. Rabuffetti, F. Rinaldi, L. Palazzolo, D. Bianchi, M.L. Trincavelli, I. Balloni, S. Daniele, S. Capaldi, G. Speranza, I. Eberini, E. Calleri
Predicting acute developmental toxicity of chemicals in embryos of the African clawed frog (Xenopus laevis): Calibration and validation of regression-based quantitative structure activity relationship models for hazard assessment of chemicals in anuran amphibians
2026 C. Novello, M.R. Di Nicola, J.L. Cm Dorne, E. Colombo, E.L. Viganò, M.E. Ortiz-Santaliestra, N. Kramer, E. Carnesecchi, A.M. Steinbach, I. Eberini, A. Williams, E. Benfenati, A. Roncaglioni
Antigen binding triggers long-range conformational changes in monoclonal antibodies
2026 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, M. Rossi, I. Eberini, F. Centola
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis
2026 N. Gacem, S. Bezukladova, F. Windener, T. Karam, L. Ottoboni, E. Brambilla, F. Ruffini, K. Soman, B. Garcia-Diaz, M.J.F. Levy, Q. Cui, A. Formato, C. Deboux, J. Chazot, R. Panic, S. Albrecht, E.N. Yilmaz, R.G. González, I. Eberini, S. Olla, A. Bresciani, N. Goebels, F. Zipp, C. Agresti, J. Antel, A.B. Evercooren, T. Kuhlmann, S.E. Baranzini, P. Panina-Bordignon, B. Nait-Oumesmar, G. Martino
Identification of neuronatin as a SERCA2b regulin-like protein and assessment of its aggregation propensity via coarse grained simulations
2026 O. Ben Mariem, L. Coppi, E. De Fabiani, I. Eberini, M. Crestani
Structure-based modeling reveals molecular basis for CYP153A6’s novel activity toward toluene derivatives
2026 Y. Wei, S. Donzella, S. Foiadelli, F. Molinari, U. Guerrini, I. Eberini
The Study of Biochemistry in Italian Universities: a Survey Promoted by GD SIB
2025 A. Marabotti, I. Eberini, M. Genova, F. Mensitieri, F. Malatesta
Benchmarking and Consensus Ranking of Inverse Folding Models for Protein-Ligand Interface Design
2025 Y. Wei, U. Guerrini, I. Eberini
Computational Strategies for Engineering Non-Heme and Heme Iron-Dependent Enzymes
2025 Y. Wei, U. Guerrini, F. Molinari, I. Eberini
In silico-identified putative inhibitors of paraspeckle assembly induce cell death by apoptosis in Multiple Myeloma cells and lead to the activation of the cGAS/STING pathway.
2025 V. Traini, D. Ronchetti, G. Fabbiano, I. Silvestris, N. Puccio, F. Torricelli, V. Manicardi, M. Barbieri, F. Colombo, L. Porretti, Y. Torrente, I. Eberini, F. Passamonti, N. Bolli, A. Neri, E. Taiana
Limonene monooxygenases Molecular Modeling
2025 Y. Wei, I. Eberini, F. Molinari
In silico investigation of mAbs conformational changes upon antigen binding: impact of glycosylation and light chain isotype
2025 D. Bianchi, O. Ben Mariem, L. Palazzolo, U. Guerrini, F. Centola, M. Rossi, S. Saporiti, I. Eberini
The Use of Machine Learning in Human Cytochrome P450s Substrate Prediction
2025 Y. Wei, U. Guerrini, I. Eberini
Structural Insights into CYP3A4–P-gp Interactions and Their Role in Personalized Autoimmune Drug Therapy
2025 Y. Wei, U. Guerrini, I. Eberini
Primitive homochiral polyester formation driven by tartaric acid and calcium availability
2025 C. Chen, R. Yi, M. Igisu, R. Afrin, M. Sithamparam, K. Chandru, Y. Ueno, L. Sun, T. Laurenzi, I. Eberini, T.P. Fraccia, A. Wang, H. James Cleaves, T.Z. Jia
Correlation Between CYP1A2 Genetic Polymorphism and Drug Response
2025 Y. Wei, U. Guerrini, I. Eberini